Assessing the utilization of antimicrobial agents in pediatric pneumonia during the era of the 13-valent pneumococcal conjugate vaccine: A retrospective, single-center study
CONCLUSION: After the introduction of PCV13 in Taiwan, no decrease in antibiotic use has been observed among children aged 6 months-3 years with a discharge diagnosis of bronchopneumonia and pneumonia.PMID:37758541 | DOI:10.1016/j.jmii.2023.09.001
Source: Journal of Microbiology, Immunology, and Infection - Category: Microbiology Authors: Leng Lin Hsin Chi Nan-Chang Chiu Ching-Ying Huang Jin-Yuan Wang Daniel Tsung-Ning Huang Source Type: research
More News: Allergy & Immunology | Children | Infectious Diseases | Meningitis Vaccine | Microbiology | Pediatrics | Pneomococcal Vaccine | Pneumonia | Study | Taiwan Health | Vaccines